NOSOTROPIC SUBSTANTIATION OF ANTI IgE ANIBODY THERAPY
This article studies the specifics of allergic diseases pathogenesis. Such common allergic diseases as bronchial asthma, allergic rhinitis and atopic dermatitis are conditioned by processes based on increase of immunoglobulin e synthesis. Omalizunab, which is a recombinant humanized monoclone anti-I...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2008-03-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/875 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849394091293409280 |
|---|---|
| author | Yu.G. Levina |
| author_facet | Yu.G. Levina |
| author_sort | Yu.G. Levina |
| collection | DOAJ |
| description | This article studies the specifics of allergic diseases pathogenesis. Such common allergic diseases as bronchial asthma, allergic rhinitis and atopic dermatitis are conditioned by processes based on increase of immunoglobulin e synthesis. Omalizunab, which is a recombinant humanized monoclone anti-Ige antibody, prevents Ige fixing to membrane receptors of mast cells and significantly reduces the level of immunoglobulin e circulating in blood.Key words: anti-Ige antibody, omalizumab, allergic diseases, Bronchial asthma, children. |
| format | Article |
| id | doaj-art-125adf090e5f4bb8b1b33da2dbef40ab |
| institution | Kabale University |
| issn | 1727-5776 2500-3089 |
| language | Russian |
| publishDate | 2008-03-01 |
| publisher | Union of pediatricians of Russia |
| record_format | Article |
| series | Педиатрическая фармакология |
| spelling | doaj-art-125adf090e5f4bb8b1b33da2dbef40ab2025-08-20T03:40:11ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892008-03-01524650870NOSOTROPIC SUBSTANTIATION OF ANTI IgE ANIBODY THERAPYYu.G. Levina0Scientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowThis article studies the specifics of allergic diseases pathogenesis. Such common allergic diseases as bronchial asthma, allergic rhinitis and atopic dermatitis are conditioned by processes based on increase of immunoglobulin e synthesis. Omalizunab, which is a recombinant humanized monoclone anti-Ige antibody, prevents Ige fixing to membrane receptors of mast cells and significantly reduces the level of immunoglobulin e circulating in blood.Key words: anti-Ige antibody, omalizumab, allergic diseases, Bronchial asthma, children.https://www.pedpharma.ru/jour/article/view/875 |
| spellingShingle | Yu.G. Levina NOSOTROPIC SUBSTANTIATION OF ANTI IgE ANIBODY THERAPY Педиатрическая фармакология |
| title | NOSOTROPIC SUBSTANTIATION OF ANTI IgE ANIBODY THERAPY |
| title_full | NOSOTROPIC SUBSTANTIATION OF ANTI IgE ANIBODY THERAPY |
| title_fullStr | NOSOTROPIC SUBSTANTIATION OF ANTI IgE ANIBODY THERAPY |
| title_full_unstemmed | NOSOTROPIC SUBSTANTIATION OF ANTI IgE ANIBODY THERAPY |
| title_short | NOSOTROPIC SUBSTANTIATION OF ANTI IgE ANIBODY THERAPY |
| title_sort | nosotropic substantiation of anti ige anibody therapy |
| url | https://www.pedpharma.ru/jour/article/view/875 |
| work_keys_str_mv | AT yuglevina nosotropicsubstantiationofantiigeanibodytherapy |